Cargando…
Nonaminoglycoside compounds induce readthrough of nonsense mutations
Large numbers of genetic disorders are caused by nonsense mutations for which compound-induced readthrough of premature termination codons (PTCs) might be exploited as a potential treatment strategy. We have successfully developed a sensitive and quantitative high-throughput screening (HTS) assay, p...
Autores principales: | Du, Liutao, Damoiseaux, Robert, Nahas, Shareef, Gao, Kun, Hu, Hailiang, Pollard, Julianne M., Goldstine, Jimena, Jung, Michael E., Henning, Susanne M., Bertoni, Carmen, Gatti, Richard A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757881/ https://www.ncbi.nlm.nih.gov/pubmed/19770270 http://dx.doi.org/10.1084/jem.20081940 |
Ejemplares similares
-
Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia
por: Borgatti, Monica, et al.
Publicado: (2020) -
Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome
por: Wong, Keit Men, et al.
Publicado: (2023) -
Variable readthrough responsiveness of nonsense mutations in hemophilia A
por: Martorell, Lluis, et al.
Publicado: (2020) -
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
por: Campofelice, Ambra, et al.
Publicado: (2019) -
Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches
por: Lombardi, Silvia, et al.
Publicado: (2020)